FundedIQ
Biotechnology

Arkea Bio: Funding, Investors & Team (Oct 2026)

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

www.arkeabio.com LinkedIn Reno, United States 11-50 employees Founded 2022
Total raised
$48.5M
Rounds
3
Latest
Series A
Sep 2026

Arkea Bio has raised $48.5M across 3 funding rounds on record, the most recent a Series A of $15.0M announced in Sep 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Arkea Bio Company Profile and Key Stats

Total funding raised
$48.5M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series A
$15.0M in Sep 2026
Employees
11-50
reported band
Founded
2022
Headquarters
Reno, United States
Investors on record
6
5 named below

Latest funding round on record: Sep 2026.

Arkea Bio Funding Rounds

Date
Round
Amount
Series A
$15.0M
Series A
$7.0M
Series A
$26.5M

Arkea Bio raised $26.5M in a Series A announced in May 2024.

1.3 years later, a Series A of $7.0M was announced in Sep 2025.

1 years later, a Series A of $15.0M was announced in Sep 2026.

Arkea Bio Investors

Breakthrough Energy Ventures Grantham Foundation Overview AgriZeroNZ Rabo Ventures

6 investors are recorded in total; the 5 named above are those the record identifies.

Arkea Bio Founders and Leadership Team

Name
Role
Contact
Colin South
Founder
Locked
Frank Wooten
CEO
Locked

Contact details for the Arkea Bio team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Arkea Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
8,558
$15M

Arkea Bio's latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Arkea Bio in Biotechnology and Reno

Companies Similar to Arkea Bio

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

Arkea Bio Funding FAQs

What does Arkea Bio do?

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

How much funding has Arkea Bio raised?

Arkea Bio has raised $48.5M across 3 rounds on record. The most recent is a Series A of $15.0M announced in Sep 2026.

When did Arkea Bio last raise funding?

Arkea Bio's most recent funding round on record is a Series A of $15.0M, announced in Sep 2026.

Who has invested in Arkea Bio?

Investors on record for Arkea Bio include Breakthrough Energy Ventures, Grantham Foundation, Overview, AgriZeroNZ, Rabo Ventures. FundedIQ records 6 investors in total.

Who founded Arkea Bio?

FundedIQ lists Colin South (Founder) at Arkea Bio.

Who is the CEO of Arkea Bio?

Frank Wooten is listed as CEO at Arkea Bio.

Where is Arkea Bio headquartered?

Arkea Bio is based in Reno, Nevada, United States.

How many employees does Arkea Bio have?

Arkea Bio is in the 11-50 employee band.

When was Arkea Bio founded?

Arkea Bio was founded in 2022.

How does Arkea Bio's funding compare to other Biotechnology startups?

Arkea Bio's latest round of $15.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Arkea Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Arkea Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.